Joint (NASDAQ:JYNT) Price Target Cut to $15.00 by Analysts at Roth Mkm

by · The Cerbat Gem

Joint (NASDAQ:JYNT – Get Free Report) had its target price dropped by equities research analysts at Roth Mkm from $16.00 to $15.00 in a research report issued on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Roth Mkm’s price target would indicate a potential upside of 29.20% from the company’s previous close.

Separately, StockNews.com downgraded shares of Joint from a “buy” rating to a “hold” rating in a report on Thursday.

View Our Latest Stock Analysis on Joint

Joint Price Performance

Shares of NASDAQ JYNT traded down $0.27 during trading on Friday, hitting $11.61. The stock had a trading volume of 85,338 shares, compared to its average volume of 43,165. Joint has a 12 month low of $7.31 and a 12 month high of $17.82. The company has a market capitalization of $174.12 million, a PE ratio of -10.18 and a beta of 1.57. The firm has a fifty day moving average of $11.26 and a two-hundred day moving average of $12.96.

Joint (NASDAQ:JYNT – Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.05). The company had revenue of $30.26 million for the quarter, compared to the consensus estimate of $29.65 million. Joint had a negative net margin of 12.00% and a positive return on equity of 2.17%. On average, equities analysts expect that Joint will post 0.13 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. Squarepoint Ops LLC bought a new stake in Joint in the second quarter valued at $144,000. Sargent Investment Group LLC bought a new stake in Joint in the second quarter valued at $150,000. XTX Topco Ltd bought a new stake in Joint in the second quarter valued at $174,000. Price T Rowe Associates Inc. MD boosted its holdings in Joint by 5.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company’s stock valued at $229,000 after acquiring an additional 837 shares in the last quarter. Finally, Avondale Wealth Management boosted its holdings in Joint by 15.8% in the second quarter. Avondale Wealth Management now owns 22,000 shares of the company’s stock valued at $309,000 after acquiring an additional 3,000 shares in the last quarter. 76.88% of the stock is owned by hedge funds and other institutional investors.

Joint Company Profile

(Get Free Report)

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Recommended Stories